Natural Product (NP) Details
General Information of the NP (ID: NP2717) | |||||
---|---|---|---|---|---|
Name |
Tangeretin
|
||||
Synonyms |
Tangeritin; Ponkanetin; Pentamethoxyflavone; 4',5,6,7,8-Pentamethoxyflavone; 5,6,7,8,4'-Pentamethoxyflavone; Tangeretin (6CI); 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-; 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)chromen-4-one; UNII-I4TLA1DLX6; NSC 53909; 5,6,7,8-Tetramethoxy-2-(4-methoxyphenyl)-4-benzopyrone; 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-chromen-4-one; I4TLA1DLX6; CHEMBL73930; MLS002667634; CHEBI:9400; 4H-1-Benzopyran-4-one, 5,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-; NSC53909; Flavone, 4',5,6,7,8-pentamethoxy- (7CI,8CI); MFCD00017438; NSC-53909; Flavone, 5,6,7,8,4'-pentamethoxy; Tangeritin; NSC53909; NSC618905; 5,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one; EINECS 207-570-1; BRN 0351695; AI3-23869; 4',5,6,7,8-pentamethoxy-flavone; Tangeretin (Tangeritin); 2-(4-Methoxyphenyl)-5,6,7,8-tetramethoxy-4H-1-benzopyran-4-one; Spectrum2_001698; Spectrum3_000920; Spectrum4_001019; SCHEMBL19740; KBioGR_001517; 5-18-05-00491 (Beilstein Handbook Reference); SPECTRUM1505269; SPBio_001656; Tangeretin, analytical standard; MEGxp0_001011; Tangeretin, >=95% (HPLC); ACon1_001263; KBio3_001900; DTXSID30197417; Flavone,5,6,7,8-pentamethoxy-; HMS3651A22; HY-N0133; ZINC1531699; 4'',5,6,7,8-pentamethoxyflavone; 4H-1-Benzopyran-4-one, 2-(4-methoxyphenyl)-5,6,7,8-tetramethoxy-; 5,6,7,8,4''-Pentamethoxyflavone; BDBM50209218; CCG-38782; CT0015; LMPK12111443; NSC618905; s2363; AKOS015895209; AC-1699; CS-5484; MCULE-1727108016; NSC 618905; NSC-618905; SDCCGMLS-0066766.P001; Flavone, 4',5,6,7,8-pentamethoxy-; NCGC00095850-01; NCGC00095850-02; NCGC00169520-01; AK168079; AS-11637; NCI60_004330; SMR001557394; ST097546; AB0010469; FT-0632194; N2077; SW219232-1; C10190; K-9174; 481T538; SR-05000002625; CU-01000013437-2; Q-100525; Q1748737; SR-05000002625-1; BRD-K25186396-001-02-1; BRD-K25186396-001-04-7; 4H-1-Benzopyran-4-one,6,7,8-tetramethoxy-2-(4-methoxyphenyl)-; 4H-1-Benzopyran-4-one,6,7,8-tetramethoxy-2-(p-methoxyphenyl)-; 4H-1-Benzopyran-4-one, 5,6,7,8-tetra-methoxy-2-(4-methoxyphenyl)-; 5,6,7,8-Tetramethoxy-2-(4-methoxyphenyl)-4H-1-benzopyran-4-one, 9CI
Click to Show/Hide
|
||||
Species Origin | Citrus reticulata ... | Click to Show/Hide | |||
Citrus reticulata | |||||
Disease | Breast cancer [ICD-11: 2C60] | Investigative | [1] | ||
Structure |
![]() |
Click to Download Mol2D MOL |
|||
Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | |||||
Formula |
C20H20O7
|
||||
PubChem CID | |||||
Canonical SMILES |
COC1=CC=C(C=C1)C2=CC(=O)C3=C(O2)C(=C(C(=C3OC)OC)OC)OC
|
||||
InChI |
1S/C20H20O7/c1-22-12-8-6-11(7-9-12)14-10-13(21)15-16(23-2)18(24-3)20(26-5)19(25-4)17(15)27-14/h6-10H,1-5H3
|
||||
InChIKey |
ULSUXBXHSYSGDT-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 481-53-8
|
||||
Herb ID | |||||
ETMC ID | |||||
SymMap ID | |||||
TCMSP ID |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP | ||||||
5-fluorouracil | Solid tumour/cancer | Click to Show/Hide the Molecular Data of This Drug | ||||
Achieving Therapeutic Synergy | Click to Show/Hide | |||||
Representative Experiment Reporting the Effect of This Combination | [2] | |||||
Detail(s) |
Combination Info
![]() |
|||||
Molecule(s)
Regulation |
Up-regulation | Expression | BAX | Molecule Info |
Pathway MAP
|
|
Down-regulation | Expression | BCL-2 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | BID | Molecule Info |
Pathway MAP
|
||
Up-regulation | Expression | CASP9 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | JNK1 | Molecule Info |
Pathway MAP
|
||
Down-regulation | Expression | MAP1LC3A | Molecule Info |
Pathway MAP
|
||
Up-regulation | Cleavage | PARP1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | RB1 | Molecule Info |
Pathway MAP
|
||
Up-regulation | Phosphorylation | TP53 | Molecule Info |
Pathway MAP
|
||
In-vitro Model | HCT 116 | CVCL_0291 | Colon carcinoma | Homo sapiens | ||
HCT 15 | CVCL_0292 | Colon adenocarcinoma | Homo sapiens | |||
KM12-C | CVCL_9547 | Colon carcinoma | Homo sapiens | |||
Experimental
Result(s) |
Combination of TAN and 5-FU significantly accelerates apoptosis via JNK mediated pathway. |
Target and Pathway | ||||
---|---|---|---|---|
Target(s) | Multidrug resistance protein 1 (ABCB1) | Molecule Info | [3] | |
Multidrug resistance protein 2 (ABCC2) | Molecule Info | [4] | ||
Ribosomal protein S6 kinase beta-1 (S6K1) | Molecule Info | [5] | ||
KEGG Pathway | ABC transporters | Click to Show/Hide | ||
2 | Bile secretion | |||
3 | MicroRNAs in cancer | |||
4 | ErbB signaling pathway | |||
5 | HIF-1 signaling pathway | |||
6 | mTOR signaling pathway | |||
7 | PI3K-Akt signaling pathway | |||
8 | AMPK signaling pathway | |||
9 | TGF-beta signaling pathway | |||
10 | Fc gamma R-mediated phagocytosis | |||
11 | Insulin signaling pathway | |||
12 | Proteoglycans in cancer | |||
13 | Acute myeloid leukemia | |||
14 | Choline metabolism in cancer | |||
NetPath Pathway | IL2 Signaling Pathway | Click to Show/Hide | ||
2 | TCR Signaling Pathway | |||
Panther Pathway | Insulin/IGF pathway-mitogen activated protein kinase kinase/MAP kinase cascade | Click to Show/Hide | ||
2 | PDGF signaling pathway | |||
3 | PI3 kinase pathway | |||
4 | p53 pathway by glucose deprivation | |||
5 | CCKR signaling map ST | |||
Pathwhiz Pathway | Leucine Stimulation on Insulin Signaling | Click to Show/Hide | ||
Pathway Interaction Database | HIF-1-alpha transcription factor network | Click to Show/Hide | ||
2 | Insulin Pathway | |||
3 | IL4-mediated signaling events | |||
4 | CDC42 signaling events | |||
5 | Angiopoietin receptor Tie2-mediated signaling | |||
6 | Regulation of Telomerase | |||
7 | mTOR signaling pathway | |||
8 | IGF1 pathway | |||
9 | IL2 signaling events mediated by PI3K | |||
10 | Integrins in angiogenesis | |||
11 | RXR and RAR heterodimerization with other nuclear receptor | |||
12 | Signaling events mediated by Stem cell factor receptor (c-Kit) | |||
13 | a6b1 and a6b4 Integrin signaling | |||
14 | TGF-beta receptor signaling | |||
Reactome | ABC-family proteins mediated transport | Click to Show/Hide | ||
2 | mTORC1-mediated signalling | |||
WikiPathways | Nuclear Receptors in Lipid Metabolism and Toxicity | Click to Show/Hide | ||
2 | NRF2 pathway | |||
3 | Irinotecan Pathway | |||
4 | Drug Induction of Bile Acid Pathway | |||
5 | Codeine and Morphine Metabolism | |||
6 | Abacavir transport and metabolism | |||
7 | Multi Drug Resistance Protein 1 (Glycoprotein 1) Regulation | |||
8 | Integrated Pancreatic Cancer Pathway | |||
9 | Allograft Rejection | |||
10 | ErbB Signaling Pathway | |||
11 | Interferon type I signaling pathways | |||
12 | G13 Signaling Pathway | |||
13 | IL-2 Signaling Pathway | |||
14 | Insulin Signaling | |||
15 | Cytoplasmic Ribosomal Proteins | |||
16 | EGF/EGFR Signaling Pathway | |||
17 | IL-4 Signaling Pathway | |||
18 | IL-6 signaling pathway | |||
19 | Kit receptor signaling pathway | |||
20 | Apoptosis-related network due to altered Notch3 in ovarian cancer | |||
21 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | |||
22 | BDNF signaling pathway | |||
23 | Interleukin-11 Signaling Pathway | |||
24 | FSH signaling pathway | |||
25 | Leptin signaling pathway | |||
26 | TSH signaling pathway | |||
27 | Signaling by Insulin receptor | |||
28 | TOR Signaling | |||
29 | AMPK Signaling | |||
30 | IL-5 Signaling Pathway |








